FDA.reportPublic FDA data

Finafta

Product NDC
58593-783
11-digit product format
585930783
Labeler code
58593
Product ID
58593-783_411e9f10-dd14-5800-e063-6294a90afb4b
Type
HUMAN OTC DRUG
Nonproprietary name
Benzocaine, Glycerin
Dosage form
LIQUID
Route
TOPICAL
Labeler
Efficient Laboratories Inc.
Application
M022
Marketing category
OTC MONOGRAPH DRUG
Marketing start
2023-09-15
Substance
BENZOCAINE; GLYCERIN
Active strength
5; 33 mg/100mL; mg/100mL
Pharmacologic classes
Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Chemical Allergen [EPC], Standardized Chemical Allergen [EPC]
NDC exclude flag
No
Listing certified through
2026-12-31
Current FDA listing
Yes

Additional Listing Data#

Finished product
Yes
Brand name base
Finafta
Listing expiration
2026-12-31

Active Ingredients#

Ingredient, Strength table
IngredientStrength
BENZOCAINE5 mg/100mL
GLYCERIN33 mg/100mL

Harmonized Identifiers#

Field, Values table
FieldValues
UniiU3RSY48JW5, PDC6A3C0OX

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
3c386306-c48a-413e-bb69-70cb268496f3Product name120210727

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
58593-783-15Finafta15 mL in 1 BOTTLE, WITH APPLICATORLIQUID157

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
58593-783FINAFTA (BENZOCAINE, GLYCERIN) LIQUID [EFFICIENT LABORATORIES INC.]6Current NDC, 1 package rows20241016_03368603-3e11-c2fa-e063-6294a90a04ea.zip

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startSampleExclude flagStatus
58593-783-155859307831515 mL in 1 BOTTLE, WITH APPLICATOR (58593-783-15) 15 ml2023-09-15NoNoHistorical